Evaluation of the interaction of novel tyrosine kinase inhibitor apatinib mesylate with bovine serum albumin using spectroscopies and theoretical calculation …

SB Kou, ZY Lin, BL Wang, JH Shi… - Journal of Biomolecular …, 2021 - Taylor & Francis
Apatinib mesylate (APM), a novel tyrosine kinase inhibitor, has been applied in treating
various cancers. In the present study, the binding mechanism of APM with bovine serum …
被引用次数：17 相关文章

Evaluation of the interaction of novel tyrosine kinase inhibitor apatinib mesylate with bovine serum albumin using spectroscopies and theoretical calculation …

SB Kou, ZY Lin, BL Wang, JH Shi… - Journal of Biomolecular …, 2020 - europepmc.org
Apatinib mesylate (APM), a novel tyrosine kinase inhibitor, has been applied in treating
various cancers. In the present study, the binding mechanism of APM with bovine serum …

Evaluation of the interaction of novel tyrosine kinase inhibitor apatinib mesylate with bovine serum albumin using spectroscopies and theoretical calculation …

SB Kou, ZY Lin, BL Wang, JH Shi… - Journal of Biomolecular …, 2021 - ingentaconnect.com
Apatinib mesylate (APM), a novel tyrosine kinase inhibitor, has been applied in treating
various cancers. In the present study, the binding mechanism of APM with bovine serum …

Evaluation of the interaction of novel tyrosine kinase inhibitor apatinib mesylate with bovine serum albumin using spectroscopies and theoretical calculation …

SB Kou, ZY Lin, BL Wang, JH Shi… - … structure & dynamics, 2021 - pubmed.ncbi.nlm.nih.gov
Apatinib mesylate (APM), a novel tyrosine kinase inhibitor, has been applied in treating
various cancers. In the present study, the binding mechanism of APM with bovine serum …